Epix retains rights to EP-2104R

AuntMinnie.com staff writers

Jul 12, 2006

Epix Pharmaceuticals reported that Schering of Berlin is not going to exercise its option for Epix's fibrin-binding imaging agent EP-2104R. Under terms of an agreement between the firms, full rights to the product revert to Epix.

The compound is a fibrin-binding agent designed to detect blood clots using MRI. After injection the agent localizes in fibrin, allowing visualization of the clot. Epix said it completed two phase IIa studies earlier this year that evaluated the performance of EP-2104R in 52 patients.

The Cambridge, MA-based firm said that although Schering, which is undergoing a merger with Bayer, had decided not to exercise its option on the agent, it would be pursuing development collaboration with other potential partners.

By AuntMinnie.com staff writers
July 13, 2006

Related Reading

Epix files Vasovist appeal with FDA, July 4, 2006

Astrue resigns from Epix, May 8, 2006

Epix to buy Predix Pharmaceuticals, April 3, 2006

Epix adds VPs, February 23, 2006

Sales fall, losses grow for Epix in ’05, February 16, 2006

Copyright © 2006 AuntMinnie.com

Low sexual desire manifests as dimorphic brain processing on fMRI

May 15, 2024

Research presented at the ARRS annual meeting highlighted the need for more detailed breast MRI reporting for neoadjuvant chemotherapy responses. One finding highlighted was that BPE changes are underreported.

ARRS: More chemo response details needed in breast MRI reporting

May 15, 2024

Introducing Echelon Synergy next generation 1.5T MRI

Introducing Echelon Synergy next generation 1.5T MRI

February 6, 2024

2024 05 06 Arrs Shoulder Mri Thumbnail

ARRS: Shoulder MRI shows high AIGM prevalence in fatty infiltration

May 6, 2024

Low sexual desire manifests as dimorphic brain processing on fMRI

By Kate Madden Yee

Men and women with hypoactive sexual desire disorder (HSDD) show dimorphic brain processing on functional MRI, a new study has found.

May 15, 2024

ARRS: More chemo response details needed in breast MRI reporting

By Amerigo Allegretto

Several chemotherapy response characteristics are often left out of breast MRI reports.

May 15, 2024

Research presented at the ARRS annual meeting highlighted the need for more detailed breast MRI reporting for neoadjuvant chemotherapy responses. One finding highlighted was that BPE changes are underreported.

ARRS: ACR guideline changes lead to sharp uptick in breast MRI use

By Amerigo Allegretto

The use of breast MRI has increased 14-fold since the American College of Radiology (ACR) changed its guidelines in 2018.

May 13, 2024

Mri Scanner2 400

ARRS: Shoulder MRI shows high AIGM prevalence in fatty infiltration

By Amerigo Allegretto

Shoulder MRI shows a high prevalence of accessory infraglenoid muscle (AIGM) in patients with teres minor fatty infiltration (TMFI).

May 6, 2024

2024 05 06 Arrs Shoulder Mri Thumbnail

ISMRM: Machine learning plus MRI radiomics estimates brain age

By Kate Madden Yee

Using machine learning with MRI radiomics features accurately assesses brain aging, according to research presented at ISMRM 2024.

May 5, 2024

Mri Brain Disease Montage Thumb

MR elastography effective for assessing liver stiffness in children

By Kate Madden Yee

MR elastography is an effective technique for noninvasive monitoring of liver stiffness -- a surrogate for fibrosis -- in children and young adults with autoimmune liver disease, researchers have reported.

April 19, 2024

2024 04 19 7 Year Old Boy With Autoimmune Sclerosing Cholangitis

Can brain MRI for emergency imaging of dizziness be more effective?

By Kate Madden Yee

Predictors for acute conditions such as stroke could make brain MRI more effective in patients who present in the emergency department with dizziness or vertigo, according to recent research.

April 15, 2024

MEG reveals how the brain processes face-like images

A brain imaging technique called magnetoencephalography (MEG) has identified a neural network that plays a key role in face pareidolia – a tendency to see faces in nonface images.

April 8, 2024

Face Images Thumbnail

Clinical value of some knee and hip MRIs questioned

Osteoarthritis appears to be a deciding factor when it comes to certain MRIs on knees and hips in people 45 and up, according to NYU Langone Health and University at Buffalo Jacobs School of Medicine and Biomedical Sciences researchers.

April 5, 2024

MRI shows preeclampsia's effect on maternal heart, fetal brain

By Kate Madden Yee

MRI reveals the negative effects of preeclampsia on pregnant women's hearts and on the brains of their fetuses, according to research published in April.

April 5, 2024

French-led team unveils 11.7 tesla MRI scans of human brain

A research group based in Saclay, near Paris, has taken the wraps off what it claims are the world's first MRI scans of the human brain in vivo taken at a field strength of 11.7 tesla. President Macron has congratulated the researchers.

April 4, 2024

2024 04 03 Brain Scan At 11 7 Tesla

MRI reveals effects of risk factors on vulnerable brain regions

By Kate Madden Yee

MRI shows the effects particular risk factors such as diabetes, air pollution, and frequency of alcohol use have on "higher-order" brain regions located in the cerebral cortex, researchers have found.

March 27, 2024

To the left of the figure, the red-yellow color denotes the regions that degenerate earlier than the rest of the brain and are vulnerable to Alzheimer’s disease. These brain areas are higher-order regions that process and combine information coming from our different senses. To the right of the figure, each dot represents the brain data from one UK Biobank participant. The overall curve shows that, in these particularly fragile regions of the brain, there is accelerated degeneration with age. Image courtesy of Gwenaëlle Douaud, PhD, and Jordi Manuello, PhD.

Page 1 of 606